Showing 911-920 of 1784 results for "".
Bridging Gaps in LGMD Care
https://reachmd.com/programs/cme/bridging-gaps-in-lgmd-care/35884/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Closing the Loop: Structured Follow-Up and Patient Communication
https://reachmd.com/programs/cme/closing-the-loop-structured-follow-up-and-patient-communication/56708/Join Drs. Devries and Koetting evaluate screening methods for accurate diagnosis of Demodex blepharitis and optimal treatment strategies for this condition.Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
https://reachmd.com/programs/cme/incorporating-guideline-recommended-targeted-therapies-into-rr-aml-management/36181/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
https://reachmd.com/programs/cme/guideline-recommendations-in-first-line-treatment-of-her2-negative-upper-gi-cancers/37689/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingDouble-Class Refractory CLL in Community Practice: Current and Future Management
https://reachmd.com/programs/cme/double-class-refractory-cll-in-community-practice-current-and-future-management/39261/Explore expert-guided strategies for managing double-class-refractory CLL, including BTK resistance, treatment sequencing, and emerging therapeutic options.Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
https://reachmd.com/programs/cme/quick-case-strategizing-treatment-selection-in-her2-pd-l1-gastric-cancer/37692/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingEmerging Directions in Menin-Directed AML Therapy
https://reachmd.com/programs/cme/emerging-directions-in-menin-directed-aml-therapy/36184/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Applying Evidence to Clinical Practice
https://reachmd.com/programs/cme/applying-evidence-to-clinical-practice/36183/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
https://reachmd.com/programs/cme/reimagining-alzheimers-care-the-advent-of-subcutaneous-administration-of-anti-amyloid-therapy/39878/Examine subcutaneous anti-amyloid therapy in early Alzheimer disease, including maintenance dosing, trial data, and patient selection and experience.Ongoing Clinical Trials in AML With Menin Inhibitors
https://reachmd.com/programs/cme/ongoing-clinical-trials-in-aml-with-menin-inhibitors/36185/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.